Journal of Integrative Cancer Biology publishes high-quality original research articles, reviews, short communications, case reports, and clinical perspectives that explore cancer through multidisciplinary, systems-level, and translational approaches. The journal emphasizes integration of molecular, clinical, computational, and population sciences to advance a holistic understanding of cancer biology and oncology practice.

Integrative Medical, Surgical & Radiation Oncology

• Combined modality therapies and multidisciplinary treatment strategies
• Integration of chemotherapy, radiotherapy, immunotherapy, and targeted therapy
• Precision oncology, pharmacogenomics, and data-driven personalized medicine
• Image-guided, minimally invasive, and robotic cancer surgeries
• Treatment toxicity prediction, supportive oncology, and survivorship integration

Integrative Hematologic Oncology

• Leukemia, lymphoma, myeloma, and myeloproliferative disorders
• Bone marrow transplantation, cellular therapy, and immune reconstitution
• Molecular diagnostics, imaging, and integrated classification of blood cancers
• CAR-T therapy, gene editing, and next-generation immunotherapies

Integrative Cancer Biology & Tumor Microenvironment

•  Systems-level understanding of carcinogenesis and tumor progression
•  Tumor microenvironment interactions, angiogenesis, metastasis, and immune modulation  
• Cancer stem cells, signaling networks, and epigenetic regulation  Multi-omics integration (genomics, proteomics, metabolomics, transcriptomics)
•  Biomarker discovery through integrative and computational approaches

Cancer Immunology & Immunotherapy

• Immune checkpoint inhibitors, vaccines, monoclonal antibodies
• Tumor-infiltrating lymphocytes, cytokine therapy, and NK-cell research
• Immune microenvironment profiling and immune-escape mechanisms
• Emerging immunotherapeutic technologies and clinical application

Cancer Prevention, Screening & Early Detection

• Population-based cancer screening programs and diagnostic innovations
• Lifestyle, environmental, and genetic risk factors
• Early detection biomarkers, liquid biopsy, and advanced imaging
• Public health strategies and preventive oncology

Translational & Experimental Oncology

• Preclinical drug discovery, nanomedicine, and experimental therapeutics
• Organoids, 3D models, xenografts, and animal models of cancer Mechanistic studies, pathway targeting, and drug resistance research
• Translational approaches bridging laboratory findings to clinical practice

Psycho-Oncology, Survivorship & Palliative Care

• Quality of life, symptom management, and long-term survivorship
• Psychosocial oncology, mental health, and caregiver support
• Pain management, end-of-life care, and palliative interventions
• Rehabilitation, nutrition, and holistic cancer care

Oncology Technology, AI & Innovations

• AI/ML in cancer diagnosis, prognosis, and treatment planning
• Radiomics, digital pathology, and computational oncology
• Wearables, remote monitoring, and tele-oncology applications